Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Blanchet

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1996
Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primatesP J Blanchet, R Grondin, P J Bédard
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 1995
The D-1 dopamine receptor: past, present and future an idiosyncratic reviewJ W Kebabian, P J Blanchet, P Bedard
Schizophrenia Research|February 8, 2012
Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: a pilot studyPierre J Blanchet, Louise Normandeau, Pierre H Rompré
Archives of Environmental Contamination and Toxicology|July 1, 1994
Bioavailability of metals and arsenic to small mammals at a mining waste-contaminated wetlandG A Pascoe, R J Blanchet, G Linder
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
Motor response to a dopamine D3 receptor preferring agonist compared to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeysP J Blanchet, S Konitsiotis, T N Chase
Behavioural Pharmacology|March 16, 2005
Effect of amantadine on motor memory consolidation in humansA Hadj Tahar, P J Blanchet, J Doyon
Ghana Medical Journal|September 4, 2012
The effect of Ghana's National Health Insurance Scheme on health care utilisationN J Blanchet, G Fink, I Osei-Akoto
Brain Research|July 4, 1994
Excitotoxic lateral pallidotomy does not relieve L-dopa-induced dyskinesia in MPTP parkinsonian monkeysP J Blanchet, R Boucher, P J Bédard
Movement Disorders : Official Journal of the Movement Disorder Society|October 2, 1998
Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeysP J Blanchet, S Konitsiotis, T N Chase
The Journal of Organic Chemistry|October 29, 2000
Synthesis of enantiomerically pure alpha-substituted propargylic amines by reaction of organoaluminum reagents with oxazolidinesJ Blanchet, M Bonin, L Micouin, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1996
Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primatesP J Blanchet, R Grondin, P J Bédard
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 1995
The D-1 dopamine receptor: past, present and future an idiosyncratic reviewJ W Kebabian, P J Blanchet, P Bedard
Schizophrenia Research|February 8, 2012
Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: a pilot studyPierre J Blanchet, Louise Normandeau, Pierre H Rompré
Archives of Environmental Contamination and Toxicology|July 1, 1994
Bioavailability of metals and arsenic to small mammals at a mining waste-contaminated wetlandG A Pascoe, R J Blanchet, G Linder
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
Motor response to a dopamine D3 receptor preferring agonist compared to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeysP J Blanchet, S Konitsiotis, T N Chase
Behavioural Pharmacology|March 16, 2005
Effect of amantadine on motor memory consolidation in humansA Hadj Tahar, P J Blanchet, J Doyon
Ghana Medical Journal|September 4, 2012
The effect of Ghana's National Health Insurance Scheme on health care utilisationN J Blanchet, G Fink, I Osei-Akoto
Brain Research|July 4, 1994
Excitotoxic lateral pallidotomy does not relieve L-dopa-induced dyskinesia in MPTP parkinsonian monkeysP J Blanchet, R Boucher, P J Bédard
Movement Disorders : Official Journal of the Movement Disorder Society|October 2, 1998
Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeysP J Blanchet, S Konitsiotis, T N Chase
The Journal of Organic Chemistry|October 29, 2000
Synthesis of enantiomerically pure alpha-substituted propargylic amines by reaction of organoaluminum reagents with oxazolidinesJ Blanchet, M Bonin, L Micouin, et al.
Pageof 11